Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2025)
Top biotech stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Industry: Biotechnology

Overview Zen Rating Price Value Growth Financials

Momentum Sentiment Forecast Dividends Due Diligence

Biotech is Zen Rated F and is the 137th ranked industry out of 145 stock market industries

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
DNA	GINKGO BIOWORKS HOLDINGS INC	$454.98M	-65.60%	-36.10%	-43.10%	-55.30%	0.92	5.62	80.40%	-240.90%	-241.11%
MIST	MILESTONE PHARMACEUTICALS INC	$68.29M	-152.30%	-48.40%	-56.31%	-32.00%	4.74	9.10	N/A	N/A	N/A
VYNE	VYNE THERAPEUTICS INC	$21.75M	-58.20%	-49.60%	-76.47%	-83.50%	0.29	4.35	100.00%	-7,950.90%	-7,950.10%
CRVS	CORVUS PHARMACEUTICALS INC	$247.33M	-192.30%	-107.20%	-185.92%	-254.20%	1.12	1.54	N/A	N/A	N/A
RGLS	REGULUS THERAPEUTICS INC	$182.83M	-50.30%	-46.80%	-60.25%	-70.50%	0.10	10.98	N/A	N/A	N/A
HOTH	HOTH THERAPEUTICS INC	$11.27M	-103.80%	-94.80%	-118.99%	6,030.30%	0.12	9.20	N/A	N/A	N/A
CNTA	CENTESSA PHARMACEUTICALS PLC	$1.84B	-67.20%	-49.30%	-42.95%	-79.40%	0.44	9.25	N/A	N/A	N/A
ROIV	ROIVANT SCIENCES LTD	$7.86B	-4.00%	-3.40%	-3.68%	-9.10%	0.05	37.91	90.90%	-224.70%	-213.29%
CRGX	CARGO THERAPEUTICS INC	$207.70M	-42.70%	-37.70%	-43.06%	-47.10%	0.15	13.79	N/A	N/A	N/A
ELAB	PMGC HOLDINGS INC	$1.60M	-122.80%	-84.70%	-76.60%	-1,065.10%	0.35	3.36	N/A	N/A	N/A
RCUS	ARCUS BIOSCIENCES INC	$878.48M	-47.30%	-23.20%	-30.09%	-32.30%	1.37	4.50	100.00%	-109.70%	-107.75%
CERO	CERO THERAPEUTICS HOLDINGS INC	$4.79M	N/A	-144.50%	646.80%	206.50%	-4.28	0.50	N/A	N/A	N/A
HUMA	HUMACYTE INC	$223.37M	N/A	-107.70%	-118.24%	-133.30%	-3.62	2.40	N/A	N/A	N/A
GPCR	STRUCTURE THERAPEUTICS INC	$1.36B	-15.70%	-15.10%	-14.09%	-21.10%	0.05	24.74	N/A	N/A	N/A
BTAI	BIOXCEL THERAPEUTICS INC	$10.26M	N/A	-101.50%	-276.13%	-52.30%	-1.41	1.68	5.40%	-2,630.10%	-1,962.49%
VERU	VERU INC	$78.75M	-108.50%	-65.00%	-111.20%	-208.90%	0.50	4.47	31.90%	-260.90%	-252.49%
SAGE	SAGE THERAPEUTICS INC	$478.94M	-68.20%	-60.80%	-84.24%	-82.70%	0.18	7.42	77.10%	-971.50%	-971.48%
RPTX	REPARE THERAPEUTICS INC	$53.14M	-44.50%	-38.40%	-55.05%	-78.50%	0.17	6.77	100.00%	-158.40%	-155.67%
ACLX	ARCELLX INC	$3.50B	-22.30%	-14.40%	-23.48%	-24.00%	0.56	4.78	100.00%	-99.50%	-127.46%
GHRS	GH RESEARCH PLC	$495.83M	-20.10%	-19.20%	-21.33%	-35.90%	0.05	17.23	N/A	N/A	N/A
AVIR	ATEA PHARMACEUTICALS INC	$247.17M	-35.90%	-33.40%	-37.54%	-49.70%	0.06	24.85	N/A	N/A	N/A
PYXS	PYXIS ONCOLOGY INC	$65.29M	-49.20%	-39.60%	-56.99%	-50.40%	0.30	7.49	97.10%	-478.90%	-492.35%
CRSP	CRISPR THERAPEUTICS AG	$3.28B	-18.50%	-15.80%	-16.83%	-18.10%	0.16	22.07	100.00%	-981.50%	-971.93%
SVRA	SAVARA INC	$548.97M	-64.50%	-51.20%	-48.39%	-52.50%	0.24	13.73	N/A	N/A	N/A
CVKD	CADRENAL THERAPEUTICS INC	$31.58M	-202.50%	-156.00%	-143.17%	865.40%	0.36	3.77	N/A	N/A	N/A
WINT	WINDTREE THERAPEUTICS INC	$4.30M	-65.90%	-18.70%	-7.03%	38.00%	1.47	0.45	N/A	N/A	N/A
PRQR	PROQR THERAPEUTICS NV	$150.45M	-61.30%	-21.50%	-20.83%	-298.30%	0.90	3.96	100.00%	-142.00%	-137.51%
KOD	KODIAK SCIENCES INC	$217.06M	-89.10%	-45.60%	-56.84%	-79.10%	1.23	6.72	N/A	N/A	N/A
ENVB	ENVERIC BIOSCIENCES INC	$3.41M	-219.70%	-168.20%	-600.58%	-2,127.10%	0.94	1.84	N/A	N/A	N/A
NUVB	NUVATION BIO INC	$721.39M	-125.00%	-97.90%	-117.67%	-111.90%	0.17	9.04	10.10%	-7,213.80%	-7,209.42%
MNMD	MIND MEDICINE (MINDMED) INC	$469.54M	-48.20%	-37.30%	-40.41%	581.50%	0.25	7.25	N/A	N/A	N/A
SLXN	SILEXION THERAPEUTICS CORP	$7.86M	N/A	-372.10%	1,904.70%	-310.60%	-1.72	0.64	N/A	N/A	N/A
ACET	ADICET BIO INC	$48.45M	-52.50%	-45.60%	-58.32%	-119.50%	0.18	9.29	N/A	N/A	N/A
ABCL	ABCELLERA BIOLOGICS INC	$765.83M	-14.90%	-11.60%	-15.61%	-18.20%	0.29	9.81	100.00%	-564.80%	-695.02%
FDMT	4D MOLECULAR THERAPEUTICS INC	$154.65M	-28.60%	-26.70%	-30.28%	-40.30%	0.10	14.92	100.00%	-434,778.40%	-434,778.38%
OCGN	OCUGEN INC	$209.96M	-183.90%	-91.30%	-88.75%	-276.50%	1.78	2.86	100.00%	-1,331.90%	-1,331.94%
EWTX	EDGEWISE THERAPEUTICS INC	$1.41B	-26.80%	-25.70%	-28.90%	-28.70%	0.06	19.93	N/A	N/A	N/A
GOVX	GEOVAX LABS INC	$13.52M	-884.90%	-374.10%	-494.62%	2,001.60%	0.62	2.55	N/A	N/A	N/A
PDSB	PDS BIOTECHNOLOGY CORP	$56.74M	-137.90%	-66.20%	-128.47%	-360.30%	1.39	2.64	N/A	N/A	N/A
SCPH	SCPHARMACEUTICALS INC	$126.21M	-437.50%	-90.50%	-83.74%	-104.10%	7.07	7.12	68.70%	-234.40%	-213.53%
TYRA	TYRA BIOSCIENCES INC	$533.02M	-23.50%	-22.40%	-24.78%	-35.80%	0.06	23.81	N/A	N/A	N/A
REPL	REPLIMUNE GROUP INC	$696.98M	-54.80%	-43.00%	-39.56%	-50.50%	0.25	11.43	N/A	N/A	N/A
GLPG	GALAPAGOS NV	$1.77B	N/A	N/A	N/A	N/A	0.46	7.95	N/A	N/A	N/A
OSTX	OS THERAPIES INC	$34.66M	N/A	-439.50%	-749.45%	99.80%	-0.90	1.20	N/A	N/A	N/A
MAZE	MAZE THERAPEUTICS INC	$359.57M	-1.00%	2.20%	24.29%	86.70%	-0.14	9.76	100.00%	2.00%	31.88%
CYBN	CYBIN INC	$139.81M	-39.00%	-37.70%	-43.25%	-841.30%	0.06	12.60	N/A	N/A	N/A
SYRE	SPYRE THERAPEUTICS INC	$851.69M	-60.70%	-42.60%	-37.51%	-62.00%	0.18	11.26	N/A	N/A	N/A
OTLK	OUTLOOK THERAPEUTICS INC	$48.99M	N/A	-123.20%	140.00%	-6,077.60%	-1.34	0.33	N/A	N/A	N/A
ENGN	ENGENE HOLDINGS INC	$198.30M	-27.70%	-24.30%	-24.19%	-61.20%	0.14	17.16	N/A	N/A	N/A
NUVL	NUVALENT INC	$5.26B	-29.80%	-28.10%	-23.90%	-36.50%	0.07	20.96	N/A	N/A	N/A
CCCC	C4 THERAPEUTICS INC	$109.32M	-43.70%	-28.00%	-34.55%	-32.70%	0.62	5.71	100.00%	-296.00%	-295.60%
ONCY	ONCOLYTICS BIOTECH INC	$44.49M	-225.20%	-114.00%	-233.93%	-11,950.80%	2.37	2.82	N/A	N/A	N/A
CRDF	CARDIFF ONCOLOGY INC	$191.59M	-74.00%	-60.60%	-54.24%	-122.60%	0.17	7.08	100.00%	-6,655.20%	-6,651.68%
CGEM	CULLINAN THERAPEUTICS INC	$476.29M	-29.20%	-27.90%	-28.29%	-34.50%	0.05	13.53	N/A	N/A	N/A
CADL	CANDEL THERAPEUTICS INC	$235.23M	-468.80%	-118.60%	-76.56%	-2,849.50%	0.61	2.77	N/A	N/A	N/A
VERA	VERA THERAPEUTICS INC	$1.48B	-39.30%	-33.10%	-22.93%	-32.90%	0.14	25.67	N/A	N/A	N/A
ATXS	ASTRIA THERAPEUTICS INC	$291.76M	-27.40%	-26.00%	-29.16%	-37.50%	0.07	17.49	N/A	N/A	N/A
EDIT	EDITAS MEDICINE INC	$127.78M	-113.40%	-63.50%	-95.00%	-96.00%	1.54	3.75	100.00%	-733.70%	-777.23%
CUE	CUE BIOPHARMA INC	$48.53M	-172.10%	-93.90%	-215.53%	-979.40%	0.84	1.84	100.00%	-438.00%	-429.40%
PROK	PROKIDNEY CORP	$298.55M	N/A	-13.60%	-15.26%	-20.30%	-0.04	10.93	100.00%	-80,507.90%	-81,282.89%
CRNX	CRINETICS PHARMACEUTICALS INC	$3.01B	-30.90%	-27.90%	-21.70%	-39.90%	0.08	23.05	100.00%	-28,720.70%	-28,720.69%
QSI	QUANTUM-SI INC	$225.26M	-44.30%	-39.70%	-43.95%	-49.60%	0.15	11.99	52.30%	-3,303.00%	-3,301.21%
DNTH	DIANTHUS THERAPEUTICS INC	$696.15M	-23.90%	-23.00%	-23.90%	-46.60%	0.06	15.22	100.00%	-1,362.80%	-1,362.77%
ELDN	ELEDON PHARMACEUTICALS INC	$194.02M	-55.60%	-29.30%	-21.56%	-35.50%	0.50	12.42	N/A	N/A	N/A
SGMT	SAGIMET BIOSCIENCES INC	$101.42M	-26.00%	-25.40%	-29.25%	-66.40%	0.03	34.30	N/A	N/A	N/A
AURA	AURA BIOSCIENCES INC	$270.21M	-47.80%	-41.30%	-51.80%	-46.00%	0.20	10.77	N/A	N/A	N/A
BCYC	BICYCLE THERAPEUTICS PLC	$582.68M	-23.70%	-19.00%	-19.34%	-323.70%	0.21	13.81	100.00%	-479.20%	-487.78%
MURA	MURAL ONCOLOGY PLC	$44.79M	-68.20%	-59.00%	-89.75%	-145.60%	0.21	5.84	N/A	N/A	N/A
ARCT	ARCTURUS THERAPEUTICS HOLDINGS INC	$350.12M	-31.60%	-21.30%	-34.51%	-899.50%	0.43	4.67	100.00%	-53.10%	-63.12%
AGEN	AGENUS INC	$68.33M	N/A	-89.70%	-2,250.23%	1,098.40%	-1.63	0.21	99.50%	-219.80%	-105.92%
HOWL	WEREWOLF THERAPEUTICS INC	$39.94M	-73.40%	-47.10%	-58.93%	-137.60%	0.73	7.45	100.00%	-3,740.80%	-3,493.85%
CING	CINGULATE INC	$16.20M	-241.10%	-159.20%	-157.15%	-586.50%	0.99	2.55	N/A	N/A	N/A
QURE	UNIQURE NV	$766.81M	-327.10%	-35.40%	-33.57%	-21.60%	-83.43	9.74	32.40%	-883.40%	-639.35%
VIGL	VIGIL NEUROSCIENCE INC	$83.54M	-96.50%	-69.80%	-100.85%	-122.60%	0.64	2.95	N/A	N/A	N/A
OKUR	ONKURE THERAPEUTICS INC	$34.93M	-62.70%	-59.20%	-50.18%	-184.30%	0.11	10.73	N/A	N/A	N/A
BMEA	BIOMEA FUSION INC	$82.28M	-151.00%	-111.90%	-237.58%	-1,895.30%	0.55	3.15	N/A	N/A	N/A
NMRA	NEUMORA THERAPEUTICS INC	$122.62M	-69.00%	-64.00%	-84.86%	-145.20%	0.10	10.51	N/A	N/A	N/A
GLSI	GREENWICH LIFESCIENCES INC	$132.47M	-341.10%	-278.70%	-623.07%	1,523.70%	0.62	2.63	N/A	N/A	N/A
KALV	KALVISTA PHARMACEUTICALS INC	$645.81M	-106.80%	-80.60%	-67.41%	-128.10%	0.90	10.44	N/A	N/A	N/A
ALLR	ALLARITY THERAPEUTICS INC	$19.23M	-263.80%	-117.20%	-205.26%	312.30%	0.92	2.06	N/A	N/A	N/A
LTRN	LANTERN PHARMA INC	$38.72M	-72.60%	-63.40%	-97.84%	-121.00%	0.21	5.83	N/A	N/A	N/A
PCVX	VAXCYTE INC	$4.24B	-17.40%	-16.50%	-13.76%	-22.10%	0.06	12.76	N/A	N/A	N/A
BBIO	BRIDGEBIO PHARMA INC	$6.90B	N/A	-66.40%	-56.91%	-22.20%	-1.62	4.67	98.30%	-241.40%	-196.18%
RANI	RANI THERAPEUTICS HOLDINGS INC	$64.38M	-782.50%	-67.70%	-149.23%	-45.00%	16.64	1.50	100.00%	-2,920.00%	-2,430.45%
STTK	SHATTUCK LABS INC	$38.13M	-72.60%	-63.10%	-91.82%	-150.40%	0.14	8.88	100.00%	-1,318.10%	-1,318.13%
FBLG	FIBROBIOLOGICS INC	$46.04M	N/A	-94.50%	-299.57%	275.40%	5.01	1.12	N/A	N/A	N/A
GRI	GRI BIO INC	$956.15k	-266.10%	-177.40%	-247.21%	988.10%	0.42	3.43	N/A	N/A	N/A
TRML	TOURMALINE BIO INC	$433.83M	-22.30%	-21.80%	-24.40%	-27.10%	0.03	30.18	N/A	N/A	N/A
LXEO	LEXEO THERAPEUTICS INC	$122.16M	-65.10%	-54.20%	-79.13%	-380.70%	0.26	5.52	N/A	N/A	N/A
VOR	VOR BIOPHARMA INC	$89.89M	-119.70%	-82.40%	-94.07%	-124.60%	0.48	5.19	N/A	N/A	N/A
ELTX	ELICIO THERAPEUTICS INC	$81.84M	N/A	-194.40%	-308.87%	-272.80%	-3.49	1.80	N/A	N/A	N/A
ORIC	ORIC PHARMACEUTICALS INC	$362.24M	-44.50%	-40.70%	-51.28%	-53.00%	0.13	10.56	N/A	N/A	N/A
RCKT	ROCKET PHARMACEUTICALS INC	$770.93M	-63.90%	-55.40%	-52.74%	-82.10%	0.14	9.30	N/A	N/A	N/A
VTYX	VENTYX BIOSCIENCES INC	$85.36M	-48.20%	-44.30%	-51.22%	-58.10%	0.09	17.97	N/A	N/A	N/A
KYMR	KYMERA THERAPEUTICS INC	$2.16B	-28.70%	-24.20%	-24.57%	-26.40%	0.17	7.53	100.00%	-475.60%	-475.04%
XBIT	XBIOTECH INC	$88.72M	-19.80%	-18.10%	-20.52%	-183.90%	0.09	11.56	N/A	N/A	N/A
DYN	DYNE THERAPEUTICS INC	$1.25B	-49.00%	-45.20%	-48.91%	-138.60%	0.10	15.60	N/A	N/A	N/A
VYGR	VOYAGER THERAPEUTICS INC	$191.57M	-19.90%	-15.10%	-18.74%	-22.30%	0.31	5.56	100.00%	-81.30%	-80.42%
SLNO	SOLENO THERAPEUTICS INC	$3.36B	-75.30%	-63.90%	-56.25%	-84.20%	0.35	15.68	N/A	N/A	N/A
CTXR	CITIUS PHARMACEUTICALS INC	$7.30M	-54.20%	-38.30%	-51.36%	-58.80%	0.79	0.41	N/A	N/A	N/A

Biotech Stocks FAQ

What are the best biotech stocks to buy right now in Apr 2025?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best biotechnology stocks to buy right now are:

1. Protalix Biotherapeutics (NYSEMKT:PLX)

Protalix Biotherapeutics (NYSEMKT:PLX) is the #1 top biotech stock out of 661 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Protalix Biotherapeutics (NYSEMKT:PLX) is: Value: B, Growth: A, Momentum: B, Sentiment: A, Safety: C, Financials: B, and AI: C.

Protalix Biotherapeutics (NYSEMKT:PLX) has a Due Diligence Score of 23, which is -1 points lower than the biotech industry average of 24. Although this number is below the industry average, our proven quant model rates PLX as a "A".

PLX passed 7 out of 33 due diligence checks and has weak fundamentals. Protalix Biotherapeutics has seen its stock return 141.53% over the past year, overperforming other biotech stocks by 220 percentage points.

Protalix Biotherapeutics has an average 1 year price target of $15.00, an upside of 426.32% from Protalix Biotherapeutics's current stock price of $2.85.

Protalix Biotherapeutics stock has a consensus Buy recommendation according to Wall Street analysts. Of the 1 analyst covering Protalix Biotherapeutics, 0% have issued a Strong Buy rating, 100% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Aurinia Pharmaceuticals (NASDAQ:AUPH)

Aurinia Pharmaceuticals (NASDAQ:AUPH) is the #2 top biotech stock out of 661 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Aurinia Pharmaceuticals (NASDAQ:AUPH) is: Value: B, Growth: A, Momentum: C, Sentiment: A, Safety: C, Financials: B, and AI: C.

Aurinia Pharmaceuticals (NASDAQ:AUPH) has a Due Diligence Score of 57, which is 33 points higher than the biotech industry average of 24.

AUPH passed 19 out of 33 due diligence checks and has strong fundamentals. Aurinia Pharmaceuticals has seen its stock return 67.97% over the past year, overperforming other biotech stocks by 146 percentage points.

3. Catalyst Pharmaceuticals (NASDAQ:CPRX)

Catalyst Pharmaceuticals (NASDAQ:CPRX) is the #3 top biotech stock out of 661 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Catalyst Pharmaceuticals (NASDAQ:CPRX) is: Value: A, Growth: C, Momentum: C, Sentiment: A, Safety: D, Financials: A, and AI: B.

Catalyst Pharmaceuticals (NASDAQ:CPRX) has a Due Diligence Score of 76, which is 52 points higher than the biotech industry average of 24.

CPRX passed 25 out of 33 due diligence checks and has strong fundamentals. Catalyst Pharmaceuticals has seen its stock return 59.74% over the past year, overperforming other biotech stocks by 138 percentage points.

Catalyst Pharmaceuticals has an average 1 year price target of $33.20, an upside of 41.58% from Catalyst Pharmaceuticals's current stock price of $23.45.

Catalyst Pharmaceuticals stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 5 analysts covering Catalyst Pharmaceuticals, 60% have issued a Strong Buy rating, 40% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the biotech stocks with highest dividends?

Out of 5 biotech stocks that have issued dividends in the past year, the 3 biotech stocks with the highest dividend yields are:

1. Dominari Holdings (NASDAQ:DOMH)

Dominari Holdings (NASDAQ:DOMH) has an annual dividend yield of 6.68%, which is 5 percentage points higher than the biotech industry average of 1.9%.

Dominari Holdings's dividend payout ratio of -13.4% indicates that its high dividend yield might not be sustainable for the long-term.

2. Novo Nordisk (Ozempic) (NYSE:NVO)

Novo Nordisk (Ozempic) (NYSE:NVO) has an annual dividend yield of 2.6%, which is 1 percentage points higher than the biotech industry average of 1.9%. Novo Nordisk (Ozempic)'s dividend payout is not stable, having dropped more than 10% nine times in the last 10 years. Novo Nordisk (Ozempic)'s dividend has shown consistent growth over the last 10 years.

Novo Nordisk (Ozempic)'s dividend payout ratio of 45.5% indicates that its dividend yield is sustainable for the long-term.

3. Royalty Pharma (NASDAQ:RPRX)

Royalty Pharma (NASDAQ:RPRX) has an annual dividend yield of 1.34%, which is -1 percentage points lower than the biotech industry average of 1.9%. Royalty Pharma's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Royalty Pharma's dividend has shown consistent growth over the last 10 years.

Royalty Pharma's dividend payout ratio of 43.8% indicates that its dividend yield is sustainable for the long-term.

Why are biotech stocks down?

Biotech stocks were down -0.65% in the last day, and up 6% over the last week. Intensity Therapeutics was the among the top losers in the biotechnology industry, dropping -37.11% yesterday.

Intensity Therapeutics shares are trading lower after the company announced a $2.35 million public offering.

What are the most undervalued biotech stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued biotech stocks right now are:

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 71, which is 57 points higher than the biotech industry average of 14. It passed 5 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has gained 2.35% in the past year. It has overperformed other stocks in the biotech industry by 80 percentage points.

2. Puma Biotechnology (NASDAQ:PBYI)

Puma Biotechnology (NASDAQ:PBYI) is the second most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Puma Biotechnology has a valuation score of 43, which is 29 points higher than the biotech industry average of 14. It passed 3 out of 7 valuation due diligence checks.

Puma Biotechnology's stock has dropped -38.52% in the past year. It has overperformed other stocks in the biotech industry by 40 percentage points.

3. Jazz Pharmaceuticals (NASDAQ:JAZZ)

Jazz Pharmaceuticals (NASDAQ:JAZZ) is the third most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Jazz Pharmaceuticals has a valuation score of 71, which is 57 points higher than the biotech industry average of 14. It passed 5 out of 7 valuation due diligence checks.

Jazz Pharmaceuticals's stock has gained 3.14% in the past year. It has overperformed other stocks in the biotech industry by 81 percentage points.

Are biotech stocks a good buy now?

55.47% of biotech stocks rated by analysts are a strong buy right now. On average, analysts expect biotech stocks to rise by 108.65% over the next year.

1.53% of biotech stocks have a Zen Rating of A (Strong Buy), 5.03% of biotech stocks are rated B (Buy), 41.79% are rated C (Hold), 35.67% are rated D (Sell), and 15.97% are rated F (Strong Sell).

What is the average p/e ratio of the biotechnology industry?

The average P/E ratio of the biotechnology industry is -157.91x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.